Compared to the control group, the Vpr peptide significantly promoted the infiltration of various immune cells, including CD4+ T cells, CD8+ T cells, NK cells, and NKT cells, in both the right tumor (injected tumor) and the left tumor (distant tumor) while reducing the infiltration of FoxP3+ regulatory T cells (Figure 9D,E). This evidence concerns the gene CD8A and neoplasm.